DK56086D0 - 11beta-phenylgonaner, deres fremstilling og farmaceutiske praeparaterindeholdende dem - Google Patents
11beta-phenylgonaner, deres fremstilling og farmaceutiske praeparaterindeholdende demInfo
- Publication number
- DK56086D0 DK56086D0 DK56086A DK56086A DK56086D0 DK 56086 D0 DK56086 D0 DK 56086D0 DK 56086 A DK56086 A DK 56086A DK 56086 A DK56086 A DK 56086A DK 56086 D0 DK56086 D0 DK 56086D0
- Authority
- DK
- Denmark
- Prior art keywords
- phenylgonanes
- 11beta
- preparation
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853504421 DE3504421A1 (de) | 1985-02-07 | 1985-02-07 | Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate |
| DE3504421 | 1985-02-07 | ||
| DE3527517 | 1985-07-29 | ||
| DE19853527517 DE3527517A1 (de) | 1985-07-29 | 1985-07-29 | 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK56086D0 true DK56086D0 (da) | 1986-02-05 |
| DK56086A DK56086A (da) | 1986-08-08 |
| DK161709B DK161709B (da) | 1991-08-05 |
| DK161709C DK161709C (da) | 1992-01-13 |
Family
ID=25829248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK056086A DK161709C (da) | 1985-02-07 | 1986-02-05 | 13-alkyl-11beta-phenylgonaner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem samt deres anvendelse til fremstilling af laegemidler |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5089635A (da) |
| EP (1) | EP0190759B1 (da) |
| CN (1) | CN1033753C (da) |
| AU (1) | AU580843B2 (da) |
| CA (1) | CA1310630C (da) |
| DE (1) | DE3665307D1 (da) |
| DK (1) | DK161709C (da) |
| ES (1) | ES8701778A1 (da) |
| FI (1) | FI85377C (da) |
| GR (1) | GR860342B (da) |
| HU (1) | HU194904B (da) |
| IE (1) | IE58149B1 (da) |
| IL (1) | IL77762A (da) |
| NO (1) | NO171994C (da) |
| NZ (1) | NZ214998A (da) |
| PT (1) | PT81969B (da) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ214998A (en) * | 1985-02-07 | 1989-06-28 | Schering Ag | 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions |
| GB8513723D0 (en) * | 1985-05-31 | 1985-07-03 | Erba Farmitalia | 11-beta substituted steroids |
| ES2045082T3 (es) * | 1987-04-24 | 1994-01-16 | Akzo Nv | Un metodo para la preparacion de nuevos derivados 11-arilestrano y 11-arilpregnano. |
| AU625450B2 (en) * | 1987-07-16 | 1992-07-09 | Schering Aktiengesellschaft Berlin Und Bergkamen | 11beta-phenyl-4,9,15-estratrienes, their manufacture, and pharmaceutical preparations containing them |
| DE3723788A1 (de) * | 1987-07-16 | 1989-01-26 | Schering Ag | 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate |
| EP0321010B1 (en) * | 1987-12-12 | 1993-02-03 | Akzo N.V. | New 11-arylsteroid compounds |
| DE3822770A1 (de) * | 1988-07-01 | 1990-01-04 | Schering Ag | 13-alkyl-11ss-phenylgonane |
| FR2643638B1 (fr) * | 1989-02-24 | 1991-06-14 | Roussel Uclaf | Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
| FR2665901B2 (fr) * | 1989-02-24 | 1994-07-29 | Roussel Uclaf | Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments. |
| US5372996A (en) * | 1989-03-10 | 1994-12-13 | Endorecherche, Inc. | Method of treatment of androgen-related diseases |
| US5364847A (en) * | 1989-03-10 | 1994-11-15 | Endorecherche | Inhibitors of sex steroid biosynthesis and methods for their production and use |
| AU5856090A (en) * | 1989-07-07 | 1991-02-06 | Endorecherche Inc. | Androgen derivatives for use in the inhibition of sex steroid activity |
| DE69034035T2 (de) * | 1989-07-07 | 2004-01-22 | Endorecherche Inc., Ste-Foy | Methode zur behandlung androgenbedingter krankheiten |
| WO1991001958A2 (de) * | 1989-08-04 | 1991-02-21 | Schering Aktiengesellschaft Berlin Und Bergkamen | 11β-ARYL-GONA-4,9-DIEN-3-ONE |
| DE4042007A1 (de) * | 1990-12-22 | 1992-06-25 | Schering Ag | 6,7-modifizierte-11(beta)-aryl-4-estrene |
| ES2112268T3 (es) * | 1990-08-14 | 1998-04-01 | Hoechst Marion Roussel Inc | Nuevos 19-nor-esteroides que tienen en posicion 11beta una cadena carbonada que comprende una funcion amida, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. |
| US5407928A (en) * | 1990-08-15 | 1995-04-18 | Schering Aktiengesellschaft | 11β-aryl-gona-4,9-dien-3-ones |
| FR2688004A1 (fr) * | 1992-02-27 | 1993-09-03 | Roussel Uclaf | Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments. |
| CA2136304A1 (en) * | 1992-05-21 | 1993-11-25 | Fernand Labrie | Inhibitors of testosterone 5.alpha.-reductase activity |
| DE4332283A1 (de) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE4332284C2 (de) * | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US5780220A (en) * | 1994-05-19 | 1998-07-14 | Trustees Of The University Of Pennsylvania | Methods and compositions for inhibiting HIV replication |
| US5639598A (en) * | 1994-05-19 | 1997-06-17 | The Trustees Of The University Of Pennsylvania | Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions |
| US5576310A (en) * | 1994-09-20 | 1996-11-19 | Jenapharm Gmbh | 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds |
| US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
| ZA9510926B (en) | 1994-12-23 | 1996-07-03 | Schering Ag | Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception |
| US6900193B1 (en) * | 1996-05-01 | 2005-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| AU710139B2 (en) | 1996-05-01 | 1999-09-16 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | 21-substituted progesterone derivatives as new antiprogestational agents |
| IL122740A (en) * | 1997-01-15 | 2003-09-17 | Akzo Nobel Nv | 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them |
| US6090798A (en) * | 1997-12-19 | 2000-07-18 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with glucocorticoid antagonists |
| US6020328A (en) * | 1998-03-06 | 2000-02-01 | Research Triangle Institute | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| US6262042B1 (en) | 1998-05-29 | 2001-07-17 | Research Triangle Institute | 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| US5962444A (en) * | 1998-05-29 | 1999-10-05 | Research Triangle Institute | 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| EP1285927A3 (de) * | 2001-08-16 | 2005-06-29 | Schering Aktiengesellschaft | Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems |
| DE10236405A1 (de) * | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| DE102009034367A1 (de) * | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| ES2762243T3 (es) | 2010-05-26 | 2020-05-22 | Corcept Therapeutics Inc | Tratamiento de distrofia muscular |
| AU2016226451B2 (en) | 2015-03-02 | 2019-12-19 | Corcept Therapeutics, Inc. | Use of glucocorticoid receptor antagonist and somatostatin analogues to treat ACTH-secreting tumors |
| CN107530339B (zh) | 2015-03-30 | 2021-03-16 | 科赛普特治疗学股份有限公司 | 糖皮质激素受体拮抗剂联合糖皮质激素用于治疗肾上腺功能不全 |
| MX383318B (es) | 2015-08-13 | 2025-03-13 | Corcept Therapeutics Inc | Metodo para diagnosticar de manera diferencial el sindrome de cushing dependiente de la corticotropina. |
| KR102197526B1 (ko) | 2016-01-19 | 2020-12-31 | 코어셉트 쎄라퓨틱스 인코포레이티드 | 이소성 쿠싱 증후군의 감별 진단 |
| MX2019011543A (es) | 2017-03-31 | 2019-12-16 | Corcept Therapeutics Inc | Moduladores del receptor de glucocorticoides para el tratamiento de cancer cervical. |
| ES3043682T3 (en) | 2017-06-20 | 2025-11-25 | Corcept Therapeutics Inc | Treatment of neuroepithelial tumors using selective glucocorticoid receptor modulators |
| US20240269280A1 (en) | 2020-12-18 | 2024-08-15 | Instil Bio (Uk) Limited | Processing of tumor infiltrating lymphocytes |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2377418A1 (fr) * | 1977-01-13 | 1978-08-11 | Roussel Uclaf | Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments |
| ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
| FR2522328B1 (fr) * | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
| DE3231827A1 (de) * | 1982-08-24 | 1984-03-01 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11ss-aryl-17(alpha)-alkinyl-17ss-hydroxy-4,9(10)- estradien-3-on-derivate, deren herstellung und diese enthaltende pharmazeutische praeparate |
| FR2573657B1 (fr) * | 1984-11-29 | 1989-05-12 | Roussel Uclaf | Produit comprenant une substance antiprogestomimetique et une substance uterotonique |
| NZ214998A (en) * | 1985-02-07 | 1989-06-28 | Schering Ag | 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions |
-
1986
- 1986-01-31 NZ NZ214998A patent/NZ214998A/xx unknown
- 1986-01-31 AU AU52913/86A patent/AU580843B2/en not_active Ceased
- 1986-02-02 IL IL77762A patent/IL77762A/xx not_active IP Right Cessation
- 1986-02-03 CN CN86100994A patent/CN1033753C/zh not_active Expired - Lifetime
- 1986-02-04 ES ES551625A patent/ES8701778A1/es not_active Expired
- 1986-02-05 DK DK056086A patent/DK161709C/da not_active IP Right Cessation
- 1986-02-05 GR GR860342A patent/GR860342B/el unknown
- 1986-02-05 PT PT81969A patent/PT81969B/pt not_active IP Right Cessation
- 1986-02-06 EP EP86101548A patent/EP0190759B1/de not_active Expired
- 1986-02-06 DE DE8686101548T patent/DE3665307D1/de not_active Expired
- 1986-02-06 IE IE33486A patent/IE58149B1/en not_active IP Right Cessation
- 1986-02-06 NO NO860425A patent/NO171994C/no not_active IP Right Cessation
- 1986-02-06 CA CA000501252A patent/CA1310630C/en not_active Expired - Lifetime
- 1986-02-06 HU HU86499A patent/HU194904B/hu not_active IP Right Cessation
- 1986-02-07 US US06/827,050 patent/US5089635A/en not_active Expired - Lifetime
- 1986-02-07 FI FI860559A patent/FI85377C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GR860342B (en) | 1986-06-03 |
| FI860559L (fi) | 1986-08-08 |
| IE860334L (en) | 1986-08-07 |
| HU194904B (en) | 1988-03-28 |
| FI860559A0 (fi) | 1986-02-07 |
| HUT40453A (en) | 1986-12-28 |
| AU580843B2 (en) | 1989-02-02 |
| IL77762A (en) | 1992-08-18 |
| NZ214998A (en) | 1989-06-28 |
| DK161709B (da) | 1991-08-05 |
| NO171994B (no) | 1993-02-15 |
| FI85377C (fi) | 1992-04-10 |
| DK56086A (da) | 1986-08-08 |
| AU5291386A (en) | 1986-08-14 |
| CN86100994A (zh) | 1986-10-08 |
| ES8701778A1 (es) | 1986-12-16 |
| EP0190759B1 (de) | 1989-08-30 |
| US5089635A (en) | 1992-02-18 |
| NO171994C (no) | 1993-05-26 |
| CN1033753C (zh) | 1997-01-08 |
| FI85377B (fi) | 1991-12-31 |
| DE3665307D1 (en) | 1989-10-05 |
| EP0190759A2 (de) | 1986-08-13 |
| NO860425L (no) | 1986-08-08 |
| IE58149B1 (en) | 1993-07-14 |
| PT81969A (de) | 1986-03-01 |
| PT81969B (pt) | 1988-03-03 |
| EP0190759A3 (en) | 1986-11-20 |
| ES551625A0 (es) | 1986-12-16 |
| DK161709C (da) | 1992-01-13 |
| CA1310630C (en) | 1992-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK56086D0 (da) | 11beta-phenylgonaner, deres fremstilling og farmaceutiske praeparaterindeholdende dem | |
| DK162445C (da) | Pyranopyridiner, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende pyranopyridinerne | |
| DK163923C (da) | 2-phenyl-3-aminomethyl-imidazooe1,2-aaapyridinderivater og farmaceutisk praeparat indeholdende saadanne forbindelser | |
| DK139287D0 (da) | Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler | |
| DK289487D0 (da) | Farmaceutiske praeparater til topisk applikation samt deres fremstilling og anvendelse | |
| DK288184D0 (da) | 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse | |
| NO862095L (no) | Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling. | |
| DK518687D0 (da) | Imidazo-benzoxazinoner, deres fremstilling og laegemidler indholdende forbindelserne | |
| DK164907C (da) | Piperazinderivater, deres fremstilling og farmaceutiske praeparater indeholdende dem | |
| DK272486D0 (da) | Tienopyridoner og farmaceutiske praeparater indeholdende dem | |
| DK590185D0 (da) | Imidazoderivater, deres fremstilling og laegemiddel indeholdende saadanne forbindelser | |
| DK462588D0 (da) | 5-hydroxy-3-aminokromanforbindelser, fremgangsmaade til deres fremstilling, farmaceutiske praeparater indeholdende dem og fremgangsmaader til behandling dermed | |
| DK166583C (da) | 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse | |
| DK592685D0 (da) | Imidazoderivater, deres fremstilling og laegemiddel indeholdende saadanne forbindelser | |
| DK438788D0 (da) | Alkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende dem | |
| DK218985A (da) | Aminocyklopentylaetere, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af dem | |
| DK272386D0 (da) | Quinoloner og farmaceutiske praeparater indeholdende dem | |
| DK504986A (da) | 7-acylbenzoxazinoner og deres derivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
| ZA86936B (en) | 11beta-phenyl-gonanes,their manufacture and pharmaceutical preparations containing them | |
| DK183986D0 (da) | Cyklopentylaetere, fremgangsmaade til fremstilling deraf og laegemiddelpraeparat indeholdende saadanne forbindelser | |
| DK488385A (da) | N6-bicycloadenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser | |
| DK165110C (da) | Thiazolylsulfider, fremgangsmaade til deres fremstilling og pharmaceutisk praeparat indeholdende dem | |
| DK488585D0 (da) | N6- substituerede adenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser | |
| DK183585D0 (da) | Iminothiazolidinderivater, deres fremstilling og farmaceutiske praeparater deraf | |
| DK352586D0 (da) | 11-methylen-oestr-15-ener, fremgangsmaader til deres fremstilling og farmaceutiske praeparater indeholdende disse oestrener |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |
Country of ref document: DK |